Overexpression of mcl-1 can inhibit cell death by stabilizing the outer mitochondrial membrane potential [9-14], and several recent leukemia treatment strategies have attempted to target the expression of mcl-1 by either pharmacological inhibition or siRNA-mediated downregulation [22]. This evidence concerns the gene MCL1 and leukemia.